Published :
Tables : 60
Figures : 40
Category : Healthcare
No. of Pages : 350
Report Code : HC-1150
Respiratory Care Devices Market Introduction: Respiratory Care Devices Market is estimated to value over USD 33.2 billion and register a CAGR value of over 8.8% from the forecast period 2020 to 2027. High prevalence of respiratory diseases coupled with growing levels of pollution are the major factors driving the respiratory care devices market. The rapid adoption of home healthcare has opened lucrative opportunities for manufacturers and is expected to boost the market during the forecast period. Furthermore, rising pollution levels and the increase in tobacco smoking is accelerating the growth of the market. Increase in the adoption of non-invasive ventilation is bolstering the market as well. Additionally, rapid usage of compact respiratory care devices is fueling the growth of the market . The market is bifurcated into product and end-user. Product type consists of therapeutic devices, monitoring devices, consumables & accessories, and diagnostic devices. Therapeutic devices are anticipated to witness substantial growth during the forecast period. The therapeutic devices are further segmented into humidifiers, inhalers, ventilators, positive airway pressure (PAP) devices, reusable resuscitators. Positive airway pressure is expected to be in vast demand owing to growing cases of obstructive sleep apnea. The availability of reimbursement on PAP devices in regions like North America and Europe is fueling the market. In terms of end-users, hospitals are expected to dominate the market growth. The financial capabilities of hospitals have allowed hospitals to purchase advanced instruments and acquire trained professionals. In terms of indication, chronic obstructive pulmonary disease is expected to bolster the market owing to a rising number of deaths caused by COPD. Furthermore, sleep apnea is witnessed to show notable growth owing to the ill effects of untreated sleep apnea. Based on regions, North America is expected to dictate the market growth. The increasing healthcare expenditure alongside rising cases of asthma and chronic obstructive pulmonary disease is driving the market in the region. The rise in geriatric population alongside favorable reimbursement policies is boosting the presence of the market in the region. Asia-Pacific region is expected to showcase massive growth owing to rising cases of respiratory disease and air pollution. The presence of high quality healthcare systems in countries like India, China, and South Korea is expected to drive the growth of the market in the region. Impact of COVID-19 on Respiratory Care Devices Market: There has been a surge in the demand of respiratory devices like the ventilators which shall propel the market growth. Furthermore, the governments are swiftly taking steps in making important alliances with ventilator manufacturers to tackle the threat of novel coronavirus. In the U.K., the administration has requested automobile manufacturers such as Honda, Rolls Royce and Ford to develop respiratory equipment on the lineup that produces HVAC systems for cars. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are making an agreement with the manufacturers to make sure that these manufacturers follow the regulations and norms required to manufacture a respiratory device. Prominent players of the market are: Medtronic, Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Co. Ltd., Masimo Corp., Getinge AB, Dragerwerk AG, Air Liquide, Vyaire Medical, Invacare Corp., Chart Industries Inc. Respiratory Care Devices Market Segmentation: By Product Therapeutic Devices PAP Devices Ventilators Nebulizers Humidifiers Oxygen Concentrators Inhalers Reusable Resuscitators Nitric Oxide Delivery Units Oxygen Hoods Monitoring Devices Pulse Oximeters Capnographs Gas Analyzers Diagnostic Devices Spirometers Polysomnography Devices Peak Flow Meters Other Diagnostic Devices Consumables and Accessories Masks Reusable Masks Nasal Masks Full-face Masks Nasal pillow masks Oral Masks Disposable Mask Disposable Resuscitators Tracheostomy Tubes Nasal Cannulas Other Consumables and Accessories By Indication Chronic Obstructive Pulmonary Disease (COPD) Asthma Sleep Apnea Infectious Disease Other diseases By End-User Hospitals Home Care Settings Ambulatory Care Centers By Region North America Latin America Europe Asia Pacific Middle East & Africa Respiratory Care Devices Market Video Sample: Competitive Landscape: Product launches, mergers, and acquisitions had a positive influence on the market. Fisher Paykel in 2019 launched a new product F&P Optiflow 3S, a Nasal Cannula in a bid to bolster its position in the market Philips launched its first sleep and respiratory education center in Singapore in 2018 ResMed in 2019, acquired HB Healthcare Safety. The move bolstered the supply of respiratory care devices and home-based medical equipment for sleep FutureWise Key Takeaways: Monitoring devices are expected to propel the market during the forecast period. The availability of pulse oximetry in the form of innovative products like bluetooth enabled and fingertip pulse oximeters is expected to accelerate the market growt Technological advancements in the form of E-Nose and enhanced portable respiratory devices will play a major role in strengthening the market during the forecast period Objectives of the Study: To provide with an exhaustive analysis on the global respiratory care devices market by product, by indication, by end-user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financial and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Respiratory Care Devices Market is estimated to value over USD 33.2 billion and register a CAGR value of over 8.8% from the forecast period 2020 to 2027.
High prevalence of respiratory diseases coupled with growing levels of pollution are the major factors driving the respiratory care devices market. The rapid adoption of home healthcare has opened lucrative opportunities for manufacturers and is expected to boost the market during the forecast period. Furthermore, rising pollution levels and the increase in tobacco smoking is accelerating the growth of the market. Increase in the adoption of non-invasive ventilation is bolstering the market as well. Additionally, rapid usage of compact respiratory care devices is fueling the growth of the market .
The market is bifurcated into product and end-user. Product type consists of therapeutic devices, monitoring devices, consumables & accessories, and diagnostic devices. Therapeutic devices are anticipated to witness substantial growth during the forecast period. The therapeutic devices are further segmented into humidifiers, inhalers, ventilators, positive airway pressure (PAP) devices, reusable resuscitators. Positive airway pressure is expected to be in vast demand owing to growing cases of obstructive sleep apnea. The availability of reimbursement on PAP devices in regions like North America and Europe is fueling the market.
In terms of end-users, hospitals are expected to dominate the market growth. The financial capabilities of hospitals have allowed hospitals to purchase advanced instruments and acquire trained professionals.
In terms of indication, chronic obstructive pulmonary disease is expected to bolster the market owing to a rising number of deaths caused by COPD. Furthermore, sleep apnea is witnessed to show notable growth owing to the ill effects of untreated sleep apnea.
Based on regions, North America is expected to dictate the market growth. The increasing healthcare expenditure alongside rising cases of asthma and chronic obstructive pulmonary disease is driving the market in the region. The rise in geriatric population alongside favorable reimbursement policies is boosting the presence of the market in the region.
Asia-Pacific region is expected to showcase massive growth owing to rising cases of respiratory disease and air pollution. The presence of high quality healthcare systems in countries like India, China, and South Korea is expected to drive the growth of the market in the region.
Impact of COVID-19 on Respiratory Care Devices Market: There has been a surge in the demand of respiratory devices like the ventilators which shall propel the market growth. Furthermore, the governments are swiftly taking steps in making important alliances with ventilator manufacturers to tackle the threat of novel coronavirus. In the U.K., the administration has requested automobile manufacturers such as Honda, Rolls Royce and Ford to develop respiratory equipment on the lineup that produces HVAC systems for cars. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) are making an agreement with the manufacturers to make sure that these manufacturers follow the regulations and norms required to manufacture a respiratory device.
Prominent players of the market are:
Medtronic, Philips Healthcare, ResMed Inc., Fisher & Paykel Healthcare Co. Ltd., Masimo Corp., Getinge AB, Dragerwerk AG, Air Liquide, Vyaire Medical, Invacare Corp., Chart Industries Inc.
Respiratory Care Devices Market Segmentation:
By Product
By Indication
By End-User
By Region
Respiratory Care Devices Market Video Sample:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Respiratory Care Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Respiratory Care Devices Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Respiratory Care Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Respiratory Care Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Respiratory Care Devices Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1 Therapeutic Devices 7.1.1. PAP Devices 7.1.2. Ventilators 7.1.3. Nebulizers 7.1.4. Humidifiers 7.1.5. Oxygen Concentrators 7.1.6. Inhalers 7.1.7. Reusable Resuscitators 7.1.8. Nitric Oxide Delivery Units 7.1.9. Oxygen Hoods 7.2. Monitoring Devices 7.2.1. Pulse Oximeters 7.2.2. Capnographs 7.2.3. Gas Analyzers 7.3. Diagnostic Devices 7.3.1. Spirometers 7.3.2. Polysomnography Devices 7.3.3. Peak Flow Meters 7.3.4. Other Diagnostic Devices 7.4. Consumables and Accessories 7.4.1. Masks 7.4.2. Reusable Masks 7.4.3. Nasal Masks 7.4.5. Full-face Masks 7.4.6. Nasal pillow masks 7.4.7. Oral Masks 7.4.8. Disposable Mask 7.4.9. Disposable Resuscitators 7.4.10. Tracheostomy Tubes 7.4.11. Nasal Cannulas 7.4.12. Other Consumables and Accessories 8. Global Respiratory Care Devices Market, By Indication Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Chronic Obstructive Pulmonary Disease (COPD) 8.2. Asthma 8.3. Sleep Apnea 8.4. Infectious Disease 8.5. Other diseases 9. Global Respiratory Care Devices Market, By End-User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hospitals 9.2. Home Care Settings 9.3. Ambulatory Care Centers 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Medtronic 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Philips Healthcare 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. ResMed Inc. 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Fisher & Paykel Healthcare Co. Ltd. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Masimo Corp. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Getinge AB 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Dragerwerk AG 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Air Liquide 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Vyaire Medical 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Invacare Corp. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Chart Industries Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics